初次盆腔器官脱垂及脱垂复发的危险因素:更新的系统综述与荟萃分析
本更新系统综述与荟萃分析纳入27项来自西方发达国家的随机对照试验、横断面和队列研究,共47,429名女性,评估初次盆腔器官脱垂及脱垂复发的危险因素。荟萃分析显示,出生体重、年龄、体重指数和提肛肌缺陷是初次脱垂的统计学显著危险因素,剖宫产和吸烟为保护因素;术前脱垂分期和年龄是脱垂复发的统计学显著危险因素。
要点
- 出生体重、年龄、体重指数和提肛肌缺陷是初次脱垂的统计学显著危险因素。
- 剖宫产和吸烟是初次脱垂的保护因素。
- 术前脱垂分期和年龄是脱垂复发的统计学显著危险因素。
核心结论
- 阴道分娩、产次、出生体重、年龄、体重指数、提肛肌缺陷和提肛肌裂孔面积是初次脱垂的危险因素,剖宫产和吸烟是保护因素。
- 术前脱垂分期和年龄是自体组织手术后脱垂复发的危险因素。
研究设计与样本
- 更新既往发表的系统综述并进行荟萃分析,系统检索PubMed和Embase,本次检索从2014年7月1日至2021年7月5日,既往检索从建库至2014年8月4日。
- 纳入在西方发达国家进行的、报告初次脱垂或脱垂复发危险因素多变量分析的随机对照试验、横断面研究和队列研究;脱垂定义基于解剖参考,脱垂复发定义为自体组织修复后的解剖学复发;复发研究要求术后中位随访≥1年。
- 采用纽卡斯尔-渥太华量表进行质量评估;将既往综述和本综述的数据合并为森林图并在可能时进行荟萃分析;若数据无法合并,则在≥2项研究报告多变量分析中显著关联时确定为「确认的危险因素」。
- 最终纳入27项研究,代表47,429名女性的数据(本次新纳入14项研究:8项关于初次脱垂危险因素,6项关于脱垂复发)。
主要发现
- 荟萃分析显示,出生体重(n=3,OR 1.04,95%CI 1.02-1.06)、年龄(n=3,OR 1.34,95%CI 1.23-1.47)、体重指数(n=2,OR 1.75,95%CI 1.17-2.62)和提肛肌缺陷(n=2,OR 3.99,95%CI 2.57-6.18)是初次脱垂的统计学显著危险因素。
- 荟萃分析显示,剖宫产(n=2,合并OR 0.08,95%CI 0.03-0.20)和吸烟(n=3,OR 0.59,95%CI 0.46-0.75)是初次脱垂的保护因素。
- 产次、阴道分娩和提肛肌裂孔面积被确定为「确认的危险因素」。
- 对于脱垂复发,术前脱垂分期(n=5,OR 2.68,95%CI 1.93-3.73)和年龄(n=2,OR 3.48,95%CI 1.99-6.08)是统计学显著危险因素。
局限性
- 由于异质性,并非所有研究均可合并进行荟萃分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To update a previously published systematic review and perform a meta-analysis on the risk factors for primary pelvic organ prolapse and prolapse recurrence. DATA SOURCES: PubMed and Embase were systematically searched. We searched from July 1, 2014 until July 5, 2021. The previous search was from inception until August 4, 2014. STUDY ELIGIBILITY CRITERIA: Randomized controlled trials and cross-sectional and cohort studies conducted in the Western developed countries that reported on multivariable analysis of risk factors for primary prolapse or prolapse recurrence were included. The definition of prolapse was based on anatomic references, and prolapse recurrence was defined as anatomic recurrence after native tissue repair. Studies on prolapse recurrence with a median follow-up of ≥1 year after surgery were included. METHODS: Quality assessment was performed with the Newcastle-Ottawa Scale. Data from the previous review and this review were combined into forest plots, and meta-analyses were performed where possible. If the data could not be pooled, "confirmed risk factors" were identified if ≥2 studies reported a significant association in multivariable analysis. RESULTS: After screening, 14 additional studies were selected-8 on the risk factors for primary prolapse and 6 on prolapse recurrence. Combined with the results from the previous review, 27 studies met the inclusion criteria, representing the data of 47,429 women. Not all studies could be pooled because of heterogeneity. Meta-analyses showed that birthweight (n=3, odds ratio, 1.04; 95% confidence interval, 1.02-1.06), age (n=3, odds ratio, 1.34; 95% confidence interval, 1.23-1.47), body mass index (n=2, odds ratio, 1.75; 95% confidence interval, 1.17-2.62), and levator defect (n=2, odds ratio, 3.99; 95% confidence interval, 2.57-6.18) are statistically significant risk factors, and cesarean delivery (n=2, pooled odds ratio, 0.08; 95% confidence interval, 0.03-0.20) and smoking (n=3, odds ratio, 0.59; 95% confidence interval, 0.46-0.75) are protective factors for primary prolapse. Parity, vaginal delivery, and levator hiatal area are identified as "confirmed risk factors." For prolapse recurrence, preoperative prolapse stage (n=5, odds ratio, 2.68; 95% confidence interval, 1.93-3.73) and age (n=2, odds ratio, 3.48; 95% confidence interval, 1.99-6.08) are statistically significant risk factors. CONCLUSION: Vaginal delivery, parity, birthweight, age, body mass index, levator defect, and levator hiatal area are risk factors, and cesarean delivery and smoking are protective factors for primary prolapse. Preoperative prolapse stage and younger age are risk factors for prolapse recurrence after native tissue surgery.
引用
- Schulten SFM, Claas-Quax MJ, Weemhoff M, et al. Risk factors for primary pelvic organ prolapse and prolapse recurrence: an updated systematic review and meta-analysis. Am J Obstet Gynecol. 2022. PMID: 35500611. doi:10.1016/j.ajog.2022.04.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。